The researchers retrospectively analyzed 54,636 patients receiving high-sensitivity cardiac troponin (hs-cTn) testing at emergency departments across Taiwan (May 2016–Dec 2021).
Excluding STEMI and incomplete cases, we developed a machine learning (ML) model using demographics and 23 routine lab tests from the initial blood draw to enable early NSTEMI risk stratification.
An actionable clinical decision supporting algorithm was also created based on ML-derived risk scores.
The ML model outperformed hs-cTn alone in both internal and external validation sets in terms of area under the receiver-operating characteristic curve.
Beyond model development, a clinically actionable decision algorithm using risk score was established.
Thresholds (<1.8 and ≥38.5) to define low- and high-risk groups, the model achieved a negative predictive value (NPV) of 98.8% (98.5–99.1%) for rule-out and a positive predictive value (PPV) of 78.1% (73.2–82.4%) for rule-in, encompassing 48.3% and 2.6% of patients, respectively.
When combined with the established 0 h/1 h algorithm, the ML model further enhanced early decision-making, safely ruling in/out 85.3% of patients within 1 hour, with PPV and NPV reaching 84.9% (79.5–87.7%) and 100% (99.6–100%), respectively.
In conclusion, this ML-based approach offers not only accurate prediction but also an actionable guide to support rapid, safe NSTEMI triage in emergency care.
【MORE】